Business
Thyme Care secures $60 million in Series B funding, and Neuspera Medical garners $23 million.
HIMSS24
Marilee Benson, president and cofounder of Zen Healthcare IT, talks about how the company's interoperability product enables AI tools to access healthcare data needed for use cases such as identifying patients for clinical trials.
Eversana senior vice president of health innovation, Alberta Spreafico, discusses the company's collaboration with the Digital Therapeutics Alliance to analyze frameworks and map reimbursement pathways in Europe for digital health adoption.
HIMSS24
Emmanuel Bilbault, cofounder and CEO of POSOS, says the company's AI-driven international drug database's use of medication codes enables it to cross-reference EHR data and tailor prescriptions to meet a patient's specific needs.
Kaiser Permanente Georgia VP & COO Heidi Veltman discusses how next-generation imaging can help create better outcomes by providing crisper scans and improving diagnostic visibility.
HIMSS24
Medweb's director of federal business Steven Osborne discusses the company's global teleradiology networks that operate out of remote locations with poor communications infrastructure.
If investment patterns in the first half of 2024 persist, this year could exceed year-end totals seen in 2019 and 2023, according to Rock Health's H1 2024 digital health funding report.
Unseen Capital funds entrepreneurs of early-stage healthcare companies focused on addressing the needs of underserved communities.
The company will use the funds to expand its workforce, including its sales team, in order to broaden its biopharma partnerships.
The funding comes a year after the company announced an expanded relationship with OpenAI to develop a chatbot for healthcare providers built on GPT-4.